Bessemer Group Inc Pharming Group N.V. Transaction History
Bessemer Group Inc
- $65.4 Billion
- Q3 2025
A detailed history of Bessemer Group Inc transactions in Pharming Group N.V. stock. As of the latest transaction made, Bessemer Group Inc holds 3 shares of PHAR stock, worth $50. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$50% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHAR
# of Institutions
9Shares Held
80.6KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY52.1KShares$876,5910.46% of portfolio
-
Cowen Prime Advisors LLC22.5KShares$377,5520.09% of portfolio
-
Morgan Stanley New York, NY4.36KShares$73,2070.0% of portfolio
-
Ever Source Wealth Advisors, LLC1.38KShares$23,1470.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA253Shares$4,2520.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $1.1B
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...